CAPRE-DM: Contraception and Pregnancy in Diabetes Mellitus

Sponsor
Imperial College London (Other)
Overall Status
Completed
CT.gov ID
NCT04523454
Collaborator
(none)
96
1
10
9.6

Study Details

Study Description

Brief Summary

This study seeks to expand upon and update this body of work. It will explore the knowledge and understanding women with diabetes have around pregnancy and conception, as well as establish how well prepared these women are for a pregnancy. Using this data, we will develop better services to inform women with diabetes about the contraception and pregnancy, as well inform the development of pre-conception counselling services for women with diabetes. If successful, we would anticipate seeing an improvement in performance in future National Diabetes in Pregnancy audits.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Worldwide, 44% of pregnancies are unplanned; in the UK 45% of pregnancies and one third of births are unplanned. If a woman wants 2 children, she will spend, on average, 5 years trying to conceive or being pregnant, and 30 years trying to prevent pregnancy.

    Women with diabetes are known to have 'high-risk' pregnancies. Complications for the mother include worsening diabetic control, particularly with increased hypoglycaemia in the 1st trimester; deterioration in retinopathy and nephropathy; pre-eclampsia; birth trauma due to fetal macrosomia. For the fetus, there are increased risks of congenital abnormalities; macrosomia with resultant birth trauma including shoulder dystocia; intrauterine growth restriction; miscarriage; still birth; neonatal unit admission and neonatal death.

    NICE guidance (NG3) contains a number of recommendations to prepare women with diabetes for a healthy pregnancy, and recommendations to avoid a pregnancy in poorly controlled diabetes; it also has recommendations about contraception. However, the National Diabetes in Pregnancy Audit 2019 shows that seven out of eight women are not adequately prepared pre-pregnancy, and there are still increased numbers of neonatal deaths, stillbirths, congenital anomalies, large and small for gestational age babies and neonatal unit admissions, compared to pregnancies in women without diabetes.

    The cause for these poor outcomes, despite the NICE guidance, needs to be understood to enable pregnancy outcomes to improve. One likely factor is poor patient knowledge about the complications associated with pregnancy. One study, undertaken in 2009, showed that only 35% of women with diabetes of reproductive age recalled having any discussion about pregnancy, and only 25% were aware of any of the risks associated with pregnancy. Another study in women with diabetes seen in an antenatal clinic showed that even if a woman was aware of the risks associated with diabetes in pregnancy, she often did not attend for pre-conception counselling and preparation. The reasons for this were multifactorial, including falling pregnant faster than expected, and pervious poor interactions with healthcare professionals.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    96 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Contraception and Pregnancy in Diabetes Mellitus
    Actual Study Start Date :
    Oct 2, 2020
    Actual Primary Completion Date :
    Aug 1, 2021
    Actual Study Completion Date :
    Aug 1, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Questionnaire - Number of women planning a pregnancy within the next year [1 hour]

      Quantitative data - Number of women planning a pregnancy within the next year

    2. Questionnaire - Invitation to and attendance at pre-conception counselling [1 hour]

      Quantitative data - Invitation to and attendance at pre-conception counselling

    3. Questionnaire - Current contraceptive choices [1 hour]

      Quantitative data - Current contraceptive choices

    4. Questionnaire - Knowledge of effect of diabetes on fertility [1 hour]

      Quantitative data - Knowledge of effect of diabetes on fertility

    5. Questionnaire - Number of women who have had the importance of a planned pregnancy explained to them [1 hour]

      Quantitative data - Number of women who have had the importance of a planned pregnancy explained to them

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Inclusion Criteria:
    • Women aged 18-50 years (reproductive age) who are not currently pregnant

    • Previous diagnosis of Diabetes Mellitus

    Exclusion Criteria:
    • Inability to understand and write in the English language

    • Unable to participate due to other factors, as assessed by the Chief Investigators

    • A history of gestational diabetes but not diabetes mellitus.

    • Pregnant women

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Imperial College London London United Kingdom W2 1NY

    Sponsors and Collaborators

    • Imperial College London

    Investigators

    • Principal Investigator: Rochan Agha-Jaffar, Imperial College Healthcare NHS Trust

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Imperial College London
    ClinicalTrials.gov Identifier:
    NCT04523454
    Other Study ID Numbers:
    • 20SM5701
    First Posted:
    Aug 21, 2020
    Last Update Posted:
    Sep 2, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 2, 2021